Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul 12;14(7):14620-46.
doi: 10.3390/ijms140714620.

The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence

Nina Pauline Holzapfel  1 , Boris Michael Holzapfel, Simon Champ, Jesper Feldthusen, Judith Clements, Dietmar Werner Hutmacher
Affiliations
Review

The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence

Nina Pauline Holzapfel et al. Int J Mol Sci. .

Abstract

Lycopene is a phytochemical that belongs to a group of pigments known as carotenoids. It is red, lipophilic and naturally occurring in many fruits and vegetables, with tomatoes and tomato-based products containing the highest concentrations of bioavailable lycopene. Several epidemiological studies have linked increased lycopene consumption with decreased prostate cancer risk. These findings are supported by in vitro and in vivo experiments showing that lycopene not only enhances the antioxidant response of prostate cells, but that it is even able to inhibit proliferation, induce apoptosis and decrease the metastatic capacity of prostate cancer cells. However, there is still no clearly proven clinical evidence supporting the use of lycopene in the prevention or treatment of prostate cancer, due to the only limited number of published randomized clinical trials and the varying quality of existing studies. The scope of this article is to discuss the potential impact of lycopene on prostate cancer by giving an overview about its molecular mechanisms and clinical effects.

PubMed Disclaimer

Figures

Figure 1
Figure 1
All-trans-lycopene and its metabolites, 5-cis, 9-cis, 13-cis and 15-cis-lycopene.
Figure 2
Figure 2
Potential effects of lycopene on prostate cancer cells.
See this image and copyright information in PMC

References

    1. Bray F., Lortet-Tieulent J., Ferlay J., Forman D., Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: An overview. Eur. J. Cancer. 2010;46:3040–3052. - PubMed
    1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base. International Agency for Research on Cancer; Lyon, France: 2010.
    1. Klotz L. Active surveillance for prostate cancer: Overview and update. Curr. Treat. Options Oncol. 2013;14:97–108. - PubMed
    1. Wilt T.J., MacDonald R., Hagerty K., Schellhammer P., Kramer B.S. 5-alpha-reductase inhibitors for prostate cancer prevention. Cochrane Database Syst. Rev. 2008 doi: 10.1002/14651858.CD007091. - DOI - PMC - PubMed
    1. Schmidt K., Pittler M.H., Ernst E. A profile of journals of complementary and alternative medicine. Swiss Med. Wkly. 2001;131:588–591. - PubMed

LinkOut - more resources